Pharmacogenetic assessment of antipsychotic-induced movement disorders: contribution of the dopamine D3 receptor and cytochrome P450 1A2 genes
Data up to Jan 2025
Total Citations Per Year
Abstract
References (26)
Incidence of Adverse Drug Reactions in Hospitalized Patients
1998 • 4,749 citations
Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians.
1994 • 2,716 citations
Functional significance of a C→A polymorphism in intron 1 of the cytochrome P450 CYP1A2 gene tested with caffeine
1999 • 722 citations
Tardive Dyskinesia
1982 • 660 citations
A targeted mutation of the D3 dopamine receptor gene is associated with hyperactivity in mice.
1996 • 473 citations
Dopamine D3-receptor gene variant and susceptibility to tardive dyskinesia in schizophrenic patients
1997 • 242 citations
Amino acid substitution in the dopamine D3 receptor as a useful polymorphism for investigating psychiatric disorders
1992 • 241 citations
D3 dopamine receptor mRNA is widely expressed in the human brain
1998 • 237 citations
Proposed Schizophrenia-Related Gene Polymorphism: Expression of the Ser9Gly Mutant Human Dopamine D3Receptor with the Semliki Forest Virus System
1996 • 233 citations
The relationship between paroxetine and the sparteine oxidation polymorphism
1992 • 204 citations
A functional polymorphism of the cytochrome P450 1A2 (CYP1A2) gene: association with tardive dyskinesia in schizophrenia
2000 • 169 citations
Association of the MscI Polymorphism of the Dopamine D3 Receptor Gene with Tardive Dyskinesia in Schizophrenia
1999 • 163 citations
Genotypic association between the dopamine D3 receptor and tardive dyskinesia in chronic schizophrenia
1999 • 153 citations
Dopamine Receptor Transcript Expression in Striatum and Prefrontal and Occipital Cortex
1997 • 142 citations
Polymorphic Drug Oxidation
1996 • 141 citations
Regional, reversible ultrastructural changes in rat brain with chronic neuroleptic treatment
1989 • 118 citations
Effects of smoking on fluphenazine clearance in psychiatric inpatients
1985 • 117 citations
Pharmacogenetics of antipsychotic treatment: lessons learned from clozapine
2000 • 94 citations
Biotransformation enzyme polymorphism and pesticide susceptibility.
2000 • 66 citations
Effects on locomotor activity after local application of D3 preferring compounds in discrete areas of the rat brain
1995 • 64 citations
Cigarette smoking and chlorpromazine disposition and actions
1982 • 46 citations
Chlorpromazine plasma levels, adverse effects, and tobacco smoking: case report.
1983 • 41 citations
Possible genetic factors underlying the pathophysiology of tardive dyskinesia
1994 • 33 citations
Search for a Susceptibility Locus to Tardive Dyskinesia
1997 • 30 citations
The emerging field of ecogenetics.
2000 • 29 citations
Search for a Susceptibility Locus to Tardive Dyskinesia
1997 • 27 citations